Identifying CYP2D6 intermediate and poor metabolizers among schizophrenic patients with respect to therapeutical response.

Authors

JUŘICA Jan BARTEČEK Richard ZENDULKA Ondřej KAŠPÁREK Tomáš FLODROVÁ Eva ŠULCOVÁ Alexandra

Year of publication 2010
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description The study sumarizes the knowledge of the correlation of metabolic phenotype and genotype of CYP2D6 with the therapeutical response in first episode- schizphrenic patients treated with risperidone.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info